2-cis-3-cis-Dimethylcyclopropanecarboxylic acid

Catalog No.: 
ACPATF859
CAS No.: 
34669-52-8
Molecular Formula: 
C6H10O2
Molecular Weight: 
114.14
2-cis-3-cis-Dimethylcyclopropanecarboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$168.00In stockInquiry
250mg95%$336.00In stockInquiry
1g95%$838.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-cis-3-cis-Dimethylcyclopropanecarboxylic acid
IUPAC Name(1s,2R,3S)-2,3-dimethylcyclopropane-1-carboxylic acid
Molecular FormulaC6H10O2
Molecular Weight114.14
SMILESC(O)(=O)[C@H]1[C@@H](C)[C@H]1C
InChI KeyVEQMUQZKBLIXLT-ZXFHETKHSA-N
Synonym2,3-DiMethyl-cyclopropanecarboxylic acid, (Methyl cis);rel-(1R,2S,3R)-2,3-dimethylcyclopropane-1-carboxylic acid;Cyclopropanecarboxylic acid, 2,3-dimethyl-, (1α,2α,3α)- (9CI);2-cis-3-cis-Dimethylcyclopropanecarboxylic acid;rel-(1s,2R,3S)-2,3-dimethylcyclopropane-1-carboxylic acid
CAS No.34669-52-8

Safety Data

Pictogram
Corrosive
Signal Word
Danger
Hazard Statement(s)
H314
Precautionary Statement(s)
P260-P264-P280-P301+P330+P331-P303+P361+P353-P304+P340-P305+P351+P338-P310-P321-P363-P405-P501

Synthetic Route by SureRoute

1. ACPATF859 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPATF859 route product structure diagram
    ACPATF85934669-52-8In Stock
Inquiry

2. ACPATF859 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPATF859 route product structure diagram
    ACPATF85934669-52-8In Stock
Inquiry

3. ACPATF859 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPATF859 route product structure diagram
    ACPATF85934669-52-8In Stock
Inquiry

Comments (0)